Search PubMedSearch

SEARCH · Search PubMed

Results for “Cyclotrons”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources

Ion cyclotron resonance spectroscopy. Cyclotron double resonance provides a new technique for the study of ion-molecule reaction mechanisms.

Ion cyclotron resonance spectroscopy yields information on many aspects of ion-molecule chemistry. The method is ideally suited for experiments involving ion energies below several electron volts, and hence provides a valuable complement to other techniques (27). eyclotron double resonance is uniquely suitable for establishing relationships between reactant ions and their product ions in complex ion-molecule reaction sequences. The double-resonance experiments with isotopic species yield information on reaction mechanisms and the nature of intermediate species. Ion-molecule reactions which occur at low energies are quite sensitive to the nature of functional groups and the details of molecular structure (28). Reactions of ions or neutral molecules with specific reagents in the cyclotron spectrometer can thus be used to characterize unknown species. Once the systematic ion-molecule chemistry of useful reagents has been worked out, it should be possible to proceed in a manner directly analogous to classical chemical methods. Suppose, for example, that reagents A(+), B(+), C(+), and D(+) each have characteristic reactions with different functional groups. Then these reagents can all be mixed with an unknown neutral species, X, and each of the reactions, X + A(+) --> ?, X + B(+) --> ?, . . . . can be examined. In contrast to solution chemistry, all the reagents can be added simultaneously to the unknown, since each of the specific reactions can be examined by cyclotron double resonance. The reactions which occur, the species synthesized , and the products of degradation then characterize X. The same methodology can be applied to characterize an unknown ionic epecies X(+), through use of neutral reagents A, B, C, and D. For example, proton transfer reactions to neuteal species have been applied in studying ions of mass 45 produced from various sources (29). The order of the proton affinities of the neutral reagent molecules are as follows: NH(3) isobutylene propene. Ions of mass 45 can be produced by the protonation of ethylene oxide (see structure III), the protonation of acetaldehyde (see structure IV), and the fragmentation of dimethyl ether (see structure V). Those ions might be expected to have, respectively, the three structures: Proton transfer from the mass-45 ions from sources III and IV to NH(3) and to isobutylene occurs readily, but not proton transfer to propene. For the ion from source V, proton transfer to NH3 occurs, but not proton transfer to isobutylene or propene. Thus the proton transfer reactions to various neutral reagents demonstrate that the mass-45 ions from the various sources are different. This example is only a rudimentary version of an approach to the characterization of unusual ionic species; niore sophisticated applications can follow when the systematic chemistry of more reagents is available. This approach should be ideal for comparing nonclassical carbonium ions produced by different routes. Some very interesting ionic species are produced by rearrangements in the fragmentation of molecules, following electron impact. Such molecular rearrangements frequently result in the fragmentation of an ion radical to another ion radical with the elimination of a small neutral species (30). It should be possible to run these reactions in reverse to check the postulated mechanisms. An interesting result of the systematic study of proton transfer to various functional groups is the finding that the proton affinity of various amines and pyridine is extremely high (31). Species such as VI and VII: might be expected to be very stable; they are in fact so stable that they are unreactive with respect to subsequent chemistry at the charge center. Thus, if there are other functional groups on the ion, the important reactions should occur at these functional groups. It should be possible to design species for which the presence of the charge has little influence on the reactivity of a neutral functional group. In this case the charge functions simply as an inert label which makes the study of neutral-neutral reactions accessible by cyclotron resonance: Various routes for development of the basic technique also appear to be very promising. Echo phenomena following sequences of pulsed excitation have been observed in electron cyclotron resonance (32). Analogous transient phenomena should also occur in ion cvclotron resonances (33). Pulsed-cyclotron-resonance techniques of course have intriguing analogies to nuclear-magnetic-resonance spin-echo experiments (34) and may be the technique of choice for making accurate measurements of ion-molecule-reaction cross sections as a function of energy for low ion energies. Finally, many ion-molecule reactions yield products in excited electronic states (35). For example, the reaction N(2)- + CO --> N(2) + CO- (46) has been studied by beam techniques (36). A straightforward procedure is to observe optical emission from the cyclotron spectrometer by placing a window at the end of the cyclotron cell (37). The emission can be analyzed with a crude set of optical filters, or with a high-speed spectrograph. Optical emission from the cyclotron cell can of course originate from many sources. The radiation from a specific excited product ion can be selected by a radio-frequency-optical double-resonance experiment. If, in the generai reaction A+ + B --> *C+ + D, (47) ion A+ is irradiated at its cyclotron resonance frequency, the number density of optical emitters *C+ is changed. If the irradiating frequency is modulated, then the number of optical emitters will be modulated, so that the intensity of emission from *C+ will also be modulated. When the optical emission from *C+ is analyzed in a spectrograph with a photoelectric cell, the output of the photoelectric cell can be detected with a phase sensitive detector referenced to the modulation frequency. This highly specific modulation-detection scheme should discriminate against other sources of light in the cyclotron cell.

Deuterium

Cyclotrons and positron emission tomography radiopharmaceuticals for clinical imaging.

Positron emission tomography (PET) requires positron-emitting radionuclides that emit 511-keV photons detectable by PET imagers. Positron-emitting radionuclides are commonly produced in charged particle accelerators, eg, linear accelerators or cyclotrons. The most widely available radiopharmaceuticals for PET imaging are carbon-11-, nitrogen-13-, and oxygen-15-labeled compounds, many of which, either in their normal state or incorporated in other compounds, serve as physiological tracers. Other useful PET radiopharmaceuticals include fluorine-18-, bromine-75-, gallium-68 (68Ga)-, rubidium-82 (82Rb)-, and copper-62 (62Cu)-labeled compounds. Many positron emitters have short half-lives and thus require on-site cyclotrons for application, and others (68Ga, 82Rb, and 62Cu) are available from radionuclides generators using relatively long-lived parent radionuclides. This review is divided into two sections: cyclotrons and PET radiopharmaceuticals for clinical imaging. In the cyclotron section, the principle of operation of the cyclotron, types of cyclotrons, medical cyclotrons, and production of radionuclides are discussed. In the section on PET radiopharmaceuticals, the synthesis and clinical use of PET radiopharmaceuticals are described.

Brain

The medical case for an Australian national cyclotron facility.

Both a national cyclotron and a reactor are necessary to provide Australia with the complete range of radioisotopes. For the last 17 years, Australia has been well supplied with reactor radioisotopes by the Australian Atomic Energy Commission which provides a daily nationwide distribution service, but, to be self-sufficient, Australia also needs a national cyclotron. Many cyclotron radioisotopes are too short-lived for importation, and the demand can be met only by domestic production. Despite the availability of the necessary expertise and instrumentation, Australian patients are being denied a wide range of important clinical investigations because of the lack of suitable radioisotopes, for example, krypton-81m and iodine-123. An Australian medical cyclotron is overdue. Australia and New Zealand are the only developed countries that do not possess at least one medical cyclotron. The historical events in Australia's quest for a medical cyclotron are summarized, and the medical reasons why the writers believe that Australia should now acquire its own medical cyclotron are reviewed.

Australia

Elimination of frequency drift from Fourier transform ion cyclotron resonance mass spectra by digital quadrature heterodyning: ultrahigh mass resolving power for laser-desorbed molecules.

At sufficiently low pressure, FT-ICR mass resolving power is no longer pressure-limited. Rather, the observed spectral peaks are broadened by ion cyclotron frequency drift during the detection period, due to change in shape of the coherently orbiting ion packet during detection. The frequency drift may be quantitated by Fourier transformation of each of a series of consecutive segments of the time-domain ICR signal, followed by fitting the frequency vs time behavior to a polynomial in time. Correction for that frequency drift is then achieved by a digital quadrature procedure, followed by multiplication by a weight factor which removes the frequency drift. We demonstrate a 750-fold reduction in FT-ICR mass spectral peak width for pseudomolecular (M+K)+ ions of laser-desorbed leucine enkephalin (m/delta m = 1,300,000)! Moreover, correction based on the frequency drift of ions of a given m/z also corrects for frequency drift of ions of other m/z values, as demonstrated for isotopic peaks from (M+K)+ from gramicidin S (m/z 1179). Narrowing of the FT-ICR mass spectral peaks results in a corresponding increase in peak height-to-noise ratio as well. In addition, we propose a theoretical model for frequency drift during detection of the ion cyclotron resonance signal. Simultaneous relaxation of coherent cyclotron motion and compression of the axial distribution of an initially radially coherent ion packet account for ion cyclotron frequency drift during detection. The potential energy generated by mutual ion-ion Coulomb repulsions varies with ion cyclotron orbital radius as ions undergo collisional damping.(ABSTRACT TRUNCATED AT 250 WORDS)

Cyclotrons

Measurement of total body nitrogen and oxygen by irradiation with cyclotron neutrons and 'delayed' gamma ray counting.

Measurement of total body nitrogen is assuming increasing importance in the nutritional evaluation of seriously ill patients. Nitrogen has been previously measured either by counting (i) the annihilation radiation from 13N immediately after neutron irradiation with 14 MeV neutrons or (ii) the 'prompt' gamma rays from thermal neutron capture by 14N during irradiation with 14 MeV neutrons or with those produced by isotopic sources or a cyclotron. The present work describes studies into the feasibility of measuring 13N produced by irradiation with a neutron beam from the MRC Cyclotron. A complication of this method is that 13N is also produced in a reaction with 16O. Direct measurement of oxygen by use of the reactions 16O(n, p)16N or 16O(n, 2n)15O enables this interference to be estimated. The former reaction is possible with both 14 meV and cyclotron-produced neutrons but the 7.1 s half-life of 16N requires detectors to be placed in or very close to the irradiation site. In our particular circumstances this is not possible but the more energetic cyclotron neutron spectrum allows the production of 15O which has a half-life of 2.05 min and can be measured in a remote whole-body counter. A disadvantage with the cyclotron beam, in comparison with 14 MeV neutrons, is that a higher dose is required for similar accuracy. A reproducibility of about 4% is obtained with a dose equivalent of 0.01 Sv.

Body Composition

Efficient production of high specific activity 64Cu using a biomedical cyclotron.

Copper-64 (T 1/2 = 12.7 h) is an intermediate-lived positron-emitting radionuclide that is a useful radiotracer for positron emission tomography (PET) as well as a promising radiotherapy agent for the treatment for cancer. Currently, copper-64 suitable for biomedical studies is produced in the fast neutron flux trap (irradiation of zinc with fast neutrons) at the Missouri University Research Reactor. Access to the fast neutron flux trap is only possible on a weekly basis, making the availability of this tracer very limited. In order to significantly increase the availability of this intermediate-lived radiotracer, we have investigated and developed a method for the efficient production of high specific activity Cu-64 using a small biomedical cyclotron. It has been suggested that it may be possible to produce Cu-64 on a small biomedical cyclotron utilizing the 64Ni(p,n)64Cu nuclear reaction. We have irradiated both natural nickel and enriched (95% and 98%) Ni-64 plated on gold disks. Nickel has been electroplated successfully at thicknesses of approximately 20-300 mm and bombarded with proton currents of 15-45 microA. A special water-cooled target had been designed to facilitate the irradiations on a biomedical cyclotron up to 60 microA. We have shown that it is possible to separate Cu-64 from Ni-64 and other reaction byproducts rapidly and efficiently by using ion exchange chromatography. Production runs using 19-55 mg of 95% enriched Ni-64 have yielded 150-600 mCi of Cu-64 (2.3-5.0 mCi/microAh) with specific activities of 94-310 mci/microgram Cu. The cyclotron produced Cu-64 had been used to radiolabel PTSM [pyruvaldehyde bis-(N4-methylthiosemicarbazone), used to quantify myocardial, cerebral, renal, and tumor blood flow], MAb 1A3 [monoclonal antibody MAb to colon cancer], and octreotide. A recycling technique for the costly Ni-64 target material has been developed. This technique allows the nickel eluted off the column to be recovered and reused in the electroplating of new targets with an overall efficiency of greater than 90%.

Copper Radioisotopes

A superconducting cyclotron for neutron radiation therapy.

The physical and clinical specifications of a neutron therapy facility utilizing a superconducting cyclotron are presented. The cyclotron and its support system are described. Details of the operation of the cyclotron in a hospital environment are given; the requirements of the helium liquifier and cryogenic system are described together with a summary of its mode of operation. The simplicity of the cyclotron control system is discussed. The physical characteristics of the neutron beam are described. The central axis percent depth dose curve is equivalent to that of a 4 MV x-ray beam. The depth of maximum dose occurs at approximately 9 mm depth and the surface dose is between 40% and 45%. The multirod collimator allows for the production of irregularly shaped fields of size up to 26.5 x 30 cm, without excessive exposure to operating personnel.

Cyclotrons

Oncogenic transformation of C3H/10T1/2 cells by X-rays, fast-fission neutrons, and cyclotron-produced neutrons.

Lethality and oncogenic transformation were measured in C3H/10T1/2 murine fibroblasts exposed to neutrons and X-rays at doses between 0.5 and 11 Gy. Transformation results with X-rays and low-energy, reactor-produced neutrons were used as a baseline to compare and evaluate the results obtained with high-energy, cyclotron-produced neutrons. The radiations were 100-kVp X-rays at 0.49 Gy min-1, reactor fission neutrons at 0.10 to 0.31 Gy min-1 with an 8 to 20 per cent gamma dose component, and cyclotron-produced neutrons at 0.51 Gy min-1 with mean energy 38 MeV and an 8 per cent gamma dose component. The radiobiological effectiveness (r.b.e.) for cell lethality was 2.4 +/- 0.2 for fission neutrons and 1.7 +/- 0.1 for high-energy neutrons. The maximum proportions of transformants per thousand surviving cells were, respectively, 3.7 +/- 0.8, 6.5 +/- 0.7, and 2.3 +/- 0.6 for X-rays, fission neutrons, and cyclotron-produced neutrons. The maximum observed r.b.e. for transformation induction was 3.8 for fission neutrons and 1.2 for cyclotron neutrons. Thus, high-energy neutrons exhibit a higher r.b.e. for cell killing capacity than for oncogenic transformation in C3H/10T1/2 cells.

Animals

[Medical applications of cyclotrons (author's transl)].

Isochronous cyclotrons used to accelerate different charge particles (protons, deuterons, alphas...) at variable energies, have important medical applications, for neutron teletherapy, in vivo or in vitro activation analysis or production of short-lived radioisotopes for nuclear medicine. The characteristics of the cyclotron presently available are described for these three applications (low energy "compact" cyclotrons, cyclotrons of intermediate and high energies), and their advantages are discussed from the points of view of the medical requirements, the financial investments and the results obtained.

Activation Analysis

Cryogenic aspects of the operation of a superconducting cyclotron-based neutron therapy facility.

The Harper Hospital superconducting cyclotron, which is used for neutron radiation therapy, is a unique device. It is the first superconducting cyclotron to be installed in a hospital. The novel magnet cryostat can be rotated through 360 degrees without spilling liquid and whilst remaining vented to a low pressure return line for collection of the boil-off gas. The mode of operation of the cryogenic magnet is described in detail. Some of the problems associated with the cryogenic nature of the cyclotron including those problems encountered in operating a helium liquefaction system in a hospital are discussed. At the present time the magnet is kept cold by filling the cryostat with approximately 75 L of liquid helium each day before patient treatments begin. This is a time-consuming process. The possibility of modifying the helium gas recovery and liquefaction system so that a continuous liquid helium supply could be delivered to the magnet cryostat is discussed.

Cancer Care Facilities

Fourier-transform ion cyclotron resonance mass spectrometric evidence for the formation of alpha-chloroenethiolates and thioketenes from chloroalkene-derived, cytotoxic 4-thiaalkanoates.

The cytotoxicity of chloroalkene-derived cysteine S-conjugates is thought to be associated with the formation of alpha-chloroenethiolates and thioketenes as reactive intermediates. Recent studies indicate that the formation of 1,2-dichloroethenethiolate, which may give rise to chlorothioketene, is a key step in the bioactivation of 5,6-dichloro-4-thia-5-hexenoic acid (Fitzsimmons et al. (1995) Biochemistry 34, 4276-4286). We report here the use of Fourier-transform ion cyclotron resonance mass spectrometry to provide the first direct evidence for the formation of alpha-chloroenethiolate and thioketene species from a cytotoxic 4-thiaalkanoate. The bioactivation of 5,6-dichloro-4-thia-5-hexenoic acid involves conversion to the corresponding CoA thioester 5,6-dichloro-4-thia-5-hexenoyl-CoA and subsequent processing by the fatty acid beta-oxidation pathway. It has been proposed that the bioactivation of 5,6-dichloro-4-thia-5-hexenoyl-CoA involves loss of 1,2-dichloroethenethiolate, followed by loss of chloride to form chlorothioketene. 1,2-Dichloroethenethiolate and related alpha-chloroalkenethiolates have not been observed directly in aqueous solution. Fourier-transform ion cyclotron resonance mass spectrometric experiments show that S-propyl 5,6-dichloro-4-thia-5-hexenethioate reacts in the gas phase with base (hydroxide ion) to release 1,2-dichloroethenethiolate, which is observed directly in the mass spectrum of the products of the gas-phase reaction. Furthermore, the elimination of chloride from 1,2-dichloroethenethiolate on collision-induced decomposition is facile and provides evidence for chlorothioketene formation. Preliminary evidence for the formation of 1,2-dichloroethenethiolate and chlorothioketene from S-(1,2-dichlorovinyl)-N-acetyl-L-cysteine methyl ester was also obtained. These observations support the intermediacy of alpha-chloroenethiolates and chlorothioketenes in the bioactivation of cytotoxic, chloroalkene-derived 4-thiaalkanoates and cysteine S-conjugates and demonstrate the utility of Fourier-transform ion cyclotron mass spectrometry in studying the formation of reactive intermediates.

Acetylcysteine

Magnetic fields and intracellular calcium: effects on lymphocytes exposed to conditions for 'cyclotron resonance'.

There are a number of claims in the literature that specific combinations of low-level DC and AC magnetic fields can cause biologically significant effects. The combinations of fields required to elicit these responses fulfil the theoretical conditions for classical cyclotron resonance of the selected ion. Because of the biological importance of calcium ions any effects on them are of particular interest, for instance the claimed increase in calcium uptake by electromagnetically exposed lymphocytes. We have measured the intracellular calcium concentration, by means of a sensitive fluorescent probe, during a 60 min exposure of mouse lymphocytes to 'cyclotron resonance' conditions for calcium ions. 'Resonance' conditions at two frequencies (16 Hz and 50 Hz) were tested, with a range of DC field amplitudes used to shift the frequency up to 25% either side of the calculated optimum. Treatment of the lymphocytes with concanavalin A was used as a positive control and caused a significant increase in intracellular calcium concentration. No change in intracellular calcium concentration could be detected when lymphocytes were exposed to 'cyclotron resonance' conditions or to the other magnetic field combinations used.

Animals

Biological intercomparisons of neutron beams used for radiotherapy generated by p(+)-->Be in hospital-based cyclotrons.

The new generation of hospital-based neutron therapy facilities involve cyclotrons using protons on beryllium. The spectrum of neutrons produced includes a large and variable proportion of low-energy neutrons that are poorly penetrating but biologically effective. Cells cultured in vitro were used to compare the three US facilities at Seattle, M.D. Anderson and UCLA, together with the UK facility at Clatterbridge. Cyclotrons were compared within a given experiment on the same day using cells from a common suspension. Among the three US facilities, the relative potency factor at a depth of 25 mm differs by about 11%, with Seattle the least and UCLA the most biologically effective. Clatterbridge was compared directly with M.D. Anderson and found to be less effective by about 5%; it has a slightly lower biological effectiveness than any of the US facilities. There is evidence for an increased biological effectiveness in the build-up region, which reduces the effective skin sparing potential. There is not much difference in build-up between the three US facilities. Using the proton-on-beryllium neutron production process results in a wide spectrum of neutrons with a large but variable low-energy component. The biological effectiveness of the beam depends on target design and thickness as well as the design of the collimating system. Consequently the biological effectiveness of neutron beams generated by this process must be assessed on an individual basis. It cannot be assumed that because cyclotrons have similar accelerating energies that the relative biological effectiveness will be the same.

Animals

Calcium cyclotron resonance and diatom mobility.

The hypothesis that movement of biological ions may be predicted by cyclotron resonance theory applied to cell membranes is tested in these experiments. Diatoms (Amphora coffeaeformis) were chosen as the biosystem since they move or don't move, depending on how much calcium is transported across the membrane. The experiments demonstrate that a particular ion (calcium) is apparently moved across the cell membrane in response to the DC and AC values of magnetic flux densities (B) and the frequency derived from the cyclotron resonance theory. A clear resonance is shown and a rather sharp frequency response curve is demonstrated. The experiments also show a dose response as the AC value of the flux density is varied, and that odd harmonics of the basic cyclotron frequency are also effective.

Calcium

The potential and applications of cyclotrons in biomedical fields.

Applications of cyclotrons in biomedical fields like radioisotope production; activation and reaction analysis with charged particles and neutrons both in-vitro and in vivo types; production of fast neutron beams for therapy, etc. are described. Production yields of various isotopes in use through different nuclear reactions have been compared with the yields calculated using experimentally measured or empirically constructed excitation functions. Detection sensitivities of various elements in tissue through activation induced by protons, deuterons and alphas of different energies are presented. Fast neutron beams produced from Be, D2, D2O and 7Li targets with different sized and priced cyclotrons are critically compared. It is suggested that a Li-7, deuteron or even a heavy water target would produce a more penetrant neutron beam with relatively smaller cyclotrons than the commonly used Be target.

Fast Neutrons

Determination of ion magnetron radial distribution in Fourier transform ion cyclotron resonance mass spectrometry.

The spatial distribution of the ion cyclotron orbit 'guiding centers' (magnetron radii) in a Penning trap determines virtually all aspects of Fourier transform ion cyclotron resonance (FTICR) mass spectrometry performance. Here, we demonstrate experimentally a simple method for determining that distribution, based on measuring FTICR mass spectral peak height following dipolar excitation/dipolar detection at various stages of magnetron radial expansion. No instrumental modifications are needed. Such data will make it possible to evaluate theoretical models of space charge and to quantitate and optimize ion formation, ion injection, ion trapping, ion transfer, photodissociation and ultrahigh-resolution FTICR experiments.

Cyclotrons

Electrophilic 18F from a Siemens 11 MeV proton-only cyclotron.

Because more and more PET centres are using small proton cyclotrons there is a renewed interest in methods for the production of electrophilic 18F by proton irradiation of [18O]O2. A method for the routine production of clinically useful quantities of [18F]F2 having a specific activity of 35 Ci/mmol has been developed and implemented using an 11 MeV proton cyclotron and [18O]O2. Based on the yield, purity, reproducibility, and specific activity of [18F]F2 this is the most efficient method reported thus far.

Cyclotrons